Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Assessment of AI Program 'DRISTi' as a Screening Tool — Stella

Home/Diabetic Retinopathy (DR)/Assessment of AI Program 'DRISTi' as a Screening Tool

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Retinopathy (DR) trials

Assessment of AI Program 'DRISTi' as a Screening Tool

Trial locations(2 sites)

United States

New Century Ophthalmology - Oxford, Oxford, North Carolina

New Century Ophthalmology - Raleigh, Raleigh, North Carolina

Key details

Sponsor

Artelus AI

Enrollment target

~900 participants

Started

November 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

21 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.